Increased Clinical Studies Boosts Technological Innovations in the Global Nerve Monitoring Systems Industry

What the Market Looks Like?

The global nerve monitoring system market is estimated to be valued at USD 1.14 Billion in 2017 and is projected to reach USD 1.45 Billion by 2022 growing at a CAGR of 4.9%.

Target Audience of this Study:

• Nerve monitoring product manufacturers

• Nerve monitoring product suppliers and distributors

• Contract manufacturers

• Healthcare service providers [including hospitals, surgical centers, and ambulatory surgical centers (ASCs)]

• Research laboratories and academic institutes

• Clinical research organizations (CROs)

• Government regulatory authorities

• Independent associations and non-government organizations

• National and international regulatory authorities

• Market research firms

Download PDF Brochure @ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155669000

What Drives the Market?

The factors driving the growth of Nerve Monitoring Systems Industry are the expansion in target patient base, rising demand for surgical intervention among trauma cases rising, clinical benefits associated with nerve monitoring systems, and the growing availability of medical reimbursements for nerve monitoring in developed nations.

Market Restraints:

• Limited Awareness About Nerve Monitoring Among Healthcare Professionals

Market Opportunities:

• Increased Clinical Studies in the Field of Nerve Monitoring

• Emerging Markets

Key Questions answered in this Study:

• What are the business growth strategies adopted by key market players to maintain their market position across key geographies?

• What is the existing developmental pipeline of major nerve monitoring systems among Medtech manufacturers as well as academia?

• Growing number of trauma based surgical procedures is a key trend in clinical management. What impact trauma based surgical procedures will have on nerve monitoring systems market during the forecast period?

• What alternative technologies/therapies are currently being used for nerve monitoring worldwide? What competition they pose for key nerve monitoring systems market players.

Geographical growth scenario of nerve monitoring systems market

North America accounted for the largest share of the nerve monitoring system market

Geographically, the nerve monitoring system market is segmented into North America, Europe, Asia, and the Rest of the World. North America is estimated to account for the largest share of the market in 2017, which is driven by the presence of a large patient population accompanied by a well-established medical reimbursement policy.

Leading market players and strategies adopted

The major players of the nerve monitoring system market are Medtronic (Ireland), NuVasive (US), Nihon Kohden (Japan), Bovie Medical (US), and Natus Medical (US), Checkpoint Surgical (US), Magstim (UK), Inomed (Germany), Erbe Elektromedizin (Germany), Dr. Langer Medical (Germany), EMS Handels (Austria), Neurovision Medical (US), and Halyard Health (Georgia).

Analysis of the market developments between 2015 and 2017 revealed that several growth strategies such as product launches, acquisitions, mergers, and expansions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the nerve monitoring system market. Among these business strategies, mergers and acquisitions, were the most widely adopted growth strategies by players to strengthen their product portfolios and to remain competitive in the market.

Read More: 

https://www.marketsandmarkets.com/PressReleases/nerve-monitoring-system.asp

Here's how the Emerging Technologies are changing the Face of the Global Environmental Testing Equipment Industry

The study involved four major activities to estimate the current market size for environmental testing equipment. Exhaustive secondary research was done to collect information on the market and its different sub segments. The next step was to validate these findings, assumptions, and sizing with industry experts across value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter market breakdown and data triangulation was used to estimate the market size of segments and sub segments

What the Market Looks Like?

Recent Developments:

·       In March 2018, Agilent established a new logistics hub in Shanghai to enable rapid delivery of the company’s instrument parts, supplies, and consumables to laboratories in China.

·       In August 2016, Shimadzu acquired SINC (SINC do Brasil Instrumentaçâo Cientifica Ltda.) to strengthen its analytical and measuring instruments business in Brazil.

Key questions addressed by the report:

• Which of the product segment will dominate the global market in the next five years?
• Emerging countries have immense opportunities for the growth and adoption of environmental testing equipment, will this scenario continue in the next five years?
• Increasing environmental awareness in the emerging market is impacting the growth for developed markets. How will the pricing difference impact the overall market?
• What are the upcoming technologies in the global market?

Download PDF Brochure @ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=149706080

What Drives the Market?

The growth of the global Environmental Testing Equipment Market is primarily influenced by the following factors:

·         Rising Levels of Environmental Pollution Worldwide

·         Increasing Government Regulations and Initiatives for Environment Protection

·         Privatization of Environmental Testing Services

·         Increasing Focus on Wastewater Treatment

Major Growth Restraints:

·         High Capital Investments for Accurate and Sensitive Analytical Testing

Global Growth Opportunities:

·         Increasing Industrial Activities in Emerging Markets

·         Introduction of Innovative Rapid Technologies

Geographical growth scenario of wireless health market

North America is expected to dominate the environmental testing equipment market during the forecast period

Geographically, North America is expected to dominate the global environmental testing equipment market in 2018, while the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to the rising outdoor air pollution levels, the availability of government funding, and stringent environmental monitoring regulations.

Leading market players and strategies adopted

The major players in the environmental testing equipment analysis market include Agilent Technologies (US), Thermo Fisher Scientific (US), Waters Corporation (US), Shimadzu Corporation (Japan), Bruker (US), PerkinElmer (US), SCIEX (a subsidiary of Danaher) (US), JEOL (Japan), Analytik Jena (Germany), and Merck KGaA (Germany).

The analysis of market developments between 2016 and 2018 showed that market players adopted growth strategies such as product launches, strategic acquisitions, expansions, partnerships, agreements, and collaborations to strengthen their product portfolios and maintain a competitive position in the environmental testing equipment analysis market.

Read More: 

https://www.marketsandmarkets.com/PressReleases/environmental-testing-equipment.asp

European Hemostats & Sealants Market - Global Growth in Revenue Generation by 2024 | Emerging Trends

The study involved four major activities to estimate the current size of the hemostats and sealants (focused brands) market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

What the Market Looks Like?

The European hemostats and sealants market is projected to reach USD 89 million by 2024 from USD 63 million in 2019, at a CAGR of 7.0%. The growth of this market is majorly driven by the launch of new products and favorable reimbursement scenario. However, the shift toward minimally invasive surgeries and adverse effect of hemostats are the major factors restraining the growth of this market.

Based on focused products, Tachosil is projected to register the highest growth during the forecast period

Based on focused products, the market is segmented into Tachosil, Lyostypt, Sangustop, Veriset, Avitene, and Hemopatch. Tachosil is expected to grow at the highest CAGR during the forecast period, mainly due to the increasing demand for this product among end users.

Download PDF Brochure @

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=115823197

What Drives the Market?

The growth of this market is majorly driven by the launch of new products and favorable reimbursement scenario. However, the shift toward minimally invasive surgeries and adverse effect of hemostats are the major factors restraining the growth of this market.

Geographical growth scenario of wireless health market

UK to grow at the highest rate during the forecast period (2019–2024).

The European hemostats and sealants market is geographically segmented into Germany, UK, France, Italy, and Spain. While Germany dominated the market in 2019, the UK is expected to register the highest CAGR in the market during the forecast period. Germany holds the largest share amongst all the European countries, owing to its larger patient population and comparatively higher number of surgeries, which will require the usage of hemostats and sealants.

Leading market players and strategies adopted

Some of the prominent players in the European hemostats and sealants market are B. Braun (Germany), Medtronic (Ireland), C. R. Bard (US), Takeda (Japan), and Baxter (US).

Hemostats help in controlling bleeding at the site of wound or performing various open surgeries. The different types of products used include thrombin-based hemostats, combination hemostats, oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, and collagen-based hemostats. Of these, combination hemostats are anticipated to grow at the highest rate in Europe, as they reduce the risk of side-effects post-application

Read More: https://www.marketsandmarkets.com/PressReleases/european-hemostat-sealant.asp

Healthcare Contract Management Software Market - Emerging Industry Trends & Global Forecasts

The growing need to increase the operational efficiency of healthcare organizations while decreasing operational costs, increasing need to maintain compliance with regulatory mandates, high returns on investment are the major factors driving the growth of this market.

Key Market Restraints:

# Reluctance to Switch From Conventional Methods

# IT Infrastructural Limitations in Developing Countries

Key Market Opportunities:

# Declining Reimbursements and Competitive Rivalry Among Healthcare Payers

Key Market Challenges:

# Security Concerns

# Dearth of Skilled IT Professionals

Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=114258694

                     -:Global Industry Segmentation:-

The market for contract lifecycle management software is projected to grow at the highest CAGR during the forecast period

On the basis of software, the market for contract lifecycle management software is projected to grow at the highest rate during the forecast period. The high growth of this segment is attributed to its rising use in streamlining contract lifecycle processes and maintaining complex contract documents in the contract repository for all contracts.

The market for healthcare payers is expected to witness the highest growth during the forecast period

The market for healthcare payers is projected to grow at the highest rate during the forecast period. The high growth rate of this segment can be attributed to the rising need to minimize regulatory compliance risks among healthcare payers. In addition, implementation of contract management software is vital for healthcare payers as it helps them in the effective management of claims processing and reimbursements.

“The software segment is expected to dominate the market in 2019.”

On the basis of products and services, the healthcare contract management software market is segmented into software and services. The software segment is expected to grow at the highest CAGR during the forecast period. The high growth in this segment can be attributed to the benefits offered by healthcare contract management software, such as increased visibility, improved efficiency, minimized contract risks, and improved payment accuracy & agility, among others.

“By end user, the healthcare payers segment is expected to grow at the highest CAGR during the forecast period.”

Based on end user, the healthcare contract management software market has been segmented into healthcare providers, healthcare payers, medical device manufacturers and pharma & biotech companies, and research organizations. The healthcare payers segment is expected to grow at the highest CAGR during the forecast period. The need to accelerate medical claims processing tasks, increase drafting efficiency, align contracts with physician groups and facilities, and integrate contract data with downstream claims or reimbursement systems is expected to drive the growth of the healthcare payers segment.

Read More@ 
https://www.marketsandmarkets.com/PressReleases/healthcare-contract-management-software.asp

Key players in this market include Determine Inc. (US), CobbleStone Software (US), Concord (US), Contract Logix LLC (US), Icertis (US), Apttus Corporation (US), Optum Inc. (US), nThrive Inc. (US), Experian Plc. (Ireland), Coupa Software Inc. (US), and ScienceSoft (US).

Key players are focusing on increasing their presence in this high-growth market through both organic as well as inorganic growth strategies, such as product launches, expansions, agreements, partnerships, collaborations, and acquisitions. Due to the intense competition in this market, major market players are increasingly focusing on expanding their geographic presence in high-growth emerging markets and strengthening their competitiveness in the market by acquiring smaller players with desired manufacturing capabilities or geographic presence.

Organ Preservation Market worth 241.2 Million USD by 2021 | An Exclusive Research by MarketsandMarkets

The growth of the overall Organ Preservation Market can be contributed to rising multi-organ failure cases in aging population, technological advancements, increasing government initiatives to promote organ donation and rising number of solid-organ transplant procedures. In the coming years, the market is expected to witness the highest growth rate in the Asia-Pacific region. North America is expected to account for the largest share of the global market. However, high cost of transplantation is likely to restrain the growth of the market during the forecast period.

The organ preservation market is segmented on the basis of preservation solution, technique, organ type and region. By preservation solution, the transplantable organ preservation & transport market comprises of University of Wisconsin (UW) solution, Custodiol HTK, Perfadex and Others (Euro-Collins & Celsior). In 2016, the University of Wisconsin solution segment is estimated to account for the largest share of the transplantable organ preservation & transport market and is expected to grow at the highest rate during the forecast period. This large share can be attributed to its prolific usage in the storage of kidney, liver, and pancreas, better transplantation outcomes, less histological damage, and improved physiological function of organs.

By technique, organ preservation market comprises static cold storage, hypothermic machine perfusion and normothermic machine perfusion. In 2016, the static cold storage segment is estimated to account for the largest share of the transplantable organ preservation & transport market and hypothermic machine perfusion is expected to grow at the highest rate during the forecast period. The growth of this segment can be attributed to factors such as better long-term graft survival rates, decreased vasospasm, and ability to provide metabolic support.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=261269915

On the basis of organ type, the transplantable organ preservation & transport market is divided into kidneys, liver, lung, heart and others (Pancreas & Intestine). In 2016, the Kidneys segment is expected to account for the largest share of the market and grow at the highest rate. The growth of this segment can be attributed to factors such as rising cases of kidney failure, improvements in graft survival, and long-term graft function

On the basis of region, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the organ preservation market. Its large share can be attributed to growing cases of kidney failure, rising organ transplants, favorable reimbursements scenario within some provinces in Canada, and novel technological advancements by U.S. players. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period due to the new regulatory framework in China, and increasing organ donations in Asia-Pacific and serve as a revenue pocket for companies offering organ preservation solutions and transport systems

The major players in the organ preservation market include Organ Recovery Systems (U.S.), Xvivo Perfusion AB (Sweden), Essential Pharmaceuticals (U.S.), Dr. Franz Kohler Chemie GmbH (Germany), and Waters Medical Systems LLC (U.S.), among others.

Target Audience:

# Preservation Solutions and Devices Providers
# Life Sciences Companies
# Medical Device Manufacturers
# Market Research and Consulting Firms
# Healthcare Service Providers
# Medical Research Institutes
# Regulatory Bodies
# Venture Capitalists

Read More@ 
https://www.marketsandmarkets.com/PressReleases/organ-preservation.asp

European Hemostats & Sealants Market - Global Industry Dynamics and Expected Revenue Growth in Near Future

The growth of this market is majorly driven by the launch of new products and favorable reimbursement scenario. However, the shift toward minimally invasive surgeries and adverse effect of hemostats are the major factors restraining the growth of this market.

Key questions addressed in the report:

# What are the growth opportunities in the hemostats and sealants market across major countries in Europe in the future?

# What are the key drivers and restraints in the hemostats and sealants market?

# What are the key brands in the hemostats and sealants market?

# Which are the key countries in the hemostats and sealants market?

# What are the most preferred brands amongst end users?

Download PDF@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=115823197

Based on focused products, Tachosil is projected to register the highest growth during the forecast period

Based on focused products, the market is segmented into Tachosil, Lyostypt, Sangustop, Veriset, Avitene, and Hemopatch. Tachosil is expected to grow at the highest CAGR during the forecast period, mainly due to the increasing demand for this product among end users.

Germany commands the largest share of the market

Based on region, the hemostats and sealants (focused products) market is segmented into Germany, the UK, France, Italy, and Spain. Germany dominates the hemostats and sealants market due to its large patient population and the favorable reimbursement scenario for the usage of hemostats.

Hemostats help in controlling bleeding at the site of wound or performing various open surgeries. The different types of products used include thrombin-based hemostats, combination hemostats, oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, and collagen-based hemostats. Of these, combination hemostats are anticipated to grow at the highest rate in Europe, as they reduce the risk of side-effects post-application

Read More@ 

https://www.marketsandmarkets.com/PressReleases/european-hemostat-sealant.asp

The market for hemostats and sealants is anticipated to grow mainly due to the launch of the new products, M&A’s, and favorable reimbursement scenario in Europe. However, the increasing preference for minimally invasive surgeries and the reducing preference for the usage of hemostats while performing surgeries are expected to hinder the growth of this market during the forecast year. Leading players operating in this market are Ethicon (J&J), Baxter, Pfizer, Baxter, C. R. Bard, and B. Braun.

Focused brands for this study are Hemopatch (Baxter), Tachosil (Takeda), Veriset (Medtronic), Avitene (C. R. Bard), and Sangustop & Lyostypt (B Braun).

Global Human Microbiome Research - Increasing Collaborations Create Growth Opportunities | Major Industry Leaders

Rising aging population, increasing incidences of lifestyle diseases, gradual demand for efficient and safe medication with no side effects, and treatment of diseases having a limited success rate are driving the growth of the global Human Microbiome Market. The market is an emerging market with abundant opportunities and is expected to flourish within five to seven years owing to a number of products currently under the clinical trial phase. In this report, the global market is divided into three major segments namely, application, disease, and product.

Restraints:

• Lack of Expertise and Detailed Research
• Barriers in Proving the Causal Link Between Dysbiosis and Disease

Opportunities:

• Investigational New Drug (IND) Requirements for Fecal Microbiota
• Increasing Collaborations Create Growth Opportunities

Challenge:

• Government Regulations

Burning Issues:

• Abundant Opportunities in the Human Microbiome Field and Tremendous Research Investments
• Development of Human Microbiome Therapeutic Products

Read Some Interesting Facts About "Human Microbiome Research - Global Industry Forecasts to 2025", Here; Download PDF Brochure@ http://bit.ly/2sYazsd

                                         Global Industry Segmentation

On the basis of disease, the human microbiome market comprises of obesity, diabetes, autoimmune disorders, acute diarrhea, cancer, mental disorders, and other diseases. In 2022, the acute diarrhea segment is expected to account for the largest share and is estimated to grow at the highest CAGR during the forecast period (2022–2025).

On the basis of product, the human microbiome research spending market is characterized into instruments and consumables. The instruments segment is further divided into laboratory instruments and analyzers, while, the consumables segment is further bifurcated into kits and reagents. The consumables segment is estimated to grow at the highest CAGR during the forecast period (2016–2021) owing to the repeated purchases of consumables as compared to instruments.

On the basis of technology, the human microbiome research spending market is divided into cell culture technology, high-throughput technology, omics technology, and computational tools. The cell culture technology segment is expected to account for the largest share of the global human microbiome research spending technology market in 2016. The large share can be attributed to the increasing R&D initiatives in the field of human microbiome.

Europe is expected to account for the largest share of the global human microbiome market in 2022. The large share of this region can be attributed to its significant presence in the probiotics and prebiotics fields and the acceptance of these products by its population.

                                          -:Major Industry Leaders:-

Enterome Bioscience (France), Yakult (Japan), DuPont (U.S.), Metabiomics Corporation (U.S.), ViThera Pharmaceuticals (U.S.), Second Genome Inc. (U.S.), MicroBiome Therapeutics LLC (U.S.), Vedanta BioSciences (U.S.), Osel, Inc. (U.S.), and Merck (U.S.) are the major players in the human microbiome market. Domination of the individual segments in this market will depend on the core competencies of different players.

Companies that launch products targeted at specific indications in the human microbiome market are likely to maintain their positions in this market.

Pfizer is one such company; it releases medicines and vaccines for specific indications. The firm also entered into an agreement with Second Genome for microbiome research in obesity and metabolic disorders.

Read More@ https://www.marketsandmarkets.com/PressReleases/human-microbiome.asp

Companies in the human microbiome market are majorly focusing on expanding and entering segments for new indications and technology. The key strategy is to expand market share through acquisitions and connect financially with firms having common values and goals. To gain maximum market share, companies have been aggressively signing agreements, collaborations, and partnerships with third-party vendors. Enterome Bioscience is one such company the company focuses on developing biomarkers, companion diagnostic kits, and therapeutic solutions.

Major players that adopted this strategy include Second Genome (U.S.), Enterome Bioscience (France), Vedanta Bioscience (U.S.), and Osel, Inc. (U.S.). In April 2016, Enterome entered an agreement with Vertex Pharmaceuticals Inc. (U.S.) to research, develop, and commercialize novel small molecule FimH antagonists, to be utilized in the treatment of inflammatory bowel diseases (IBD).

Companies in the Asia-Pacific regions are also entering the field of microbiome. Yakult Honsha Co., Ltd. is one such company which is engaged in manufacturing and marketing food and beverage products. The company operates through three business segments, namely, Food and Beverages, Pharmaceuticals, and Others. The Food and Beverages segment includes juices, soft drinks, and healthy foods. This segment also includes probiotic drinks that contain Lactobacillus casei, a bacterium which improves intestinal function and immunity.